- Home
- BLIN vs AEON Comparison
BLIN vs AEON Comparison
Compare BLIN & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLIN
- AEON
- Stock Information
- Founded
- BLIN 2000
- AEON N/A
- Country
- BLIN United States
- AEON United States
- Employees
- BLIN N/A
- AEON N/A
- Industry
- BLIN EDP Services
- AEON Biotechnology: Pharmaceutical Preparations
- Sector
- BLIN Technology
- AEON Health Care
- Exchange
- BLIN Nasdaq
- AEON Nasdaq
- Market Cap
- BLIN 16.5M
- AEON 13.5M
- IPO Year
- BLIN 2007
- AEON N/A
- Fundamental
- Price
- BLIN $1.33
- AEON $0.84
- Analyst Decision
- BLIN Strong Buy
- AEON Strong Buy
- Analyst Count
- BLIN 1
- AEON 1
- Target Price
- BLIN $4.62
- AEON $7.20
- AVG Volume (30 Days)
- BLIN 112.0K
- AEON 407.1K
- Earning Date
- BLIN 08-14-2025
- AEON 11-12-2025
- Dividend Yield
- BLIN N/A
- AEON N/A
- EPS Growth
- BLIN N/A
- AEON N/A
- EPS
- BLIN N/A
- AEON N/A
- Revenue
- BLIN $15,375,000.00
- AEON N/A
- Revenue This Year
- BLIN $2.45
- AEON N/A
- Revenue Next Year
- BLIN $16.36
- AEON N/A
- P/E Ratio
- BLIN N/A
- AEON N/A
- Revenue Growth
- BLIN 0.54
- AEON N/A
- 52 Week Low
- BLIN $1.04
- AEON $0.38
- 52 Week High
- BLIN $2.80
- AEON $70.56
- Technical
- Relative Strength Index (RSI)
- BLIN 48.65
- AEON 43.87
- Support Level
- BLIN $1.26
- AEON $0.88
- Resistance Level
- BLIN $1.35
- AEON $0.96
- Average True Range (ATR)
- BLIN 0.08
- AEON 0.16
- MACD
- BLIN -0.00
- AEON -0.04
- Stochastic Oscillator
- BLIN 69.04
- AEON 2.40
About BLIN Bridgeline Digital Inc.
Bridgeline Digital Inc is a AI-powered marketing technology company that offers a suite of products that help companies grow online revenue by driving more traffic to their websites, converting more visitors to purchasers, and increasing average order value. Company software is available through a cloud-based Software as a Service (SaaS) model. It helps to maximize the performance of critical websites, intranets, and online stores. The company generates revenue from digital engagement services, subscription, perpetual licenses, maintenance, and hosting. Geographically, it derives a majority of revenue from the United States.
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.